Jason Ryan
CIK: 0001585017
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 18, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct3.6K shares- - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect9K shares at avg. $126.15$1.1M - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect5.4K shares at avg. $127.44$694K - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect3.5K shares at avg. $128.04$442K - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect9.9K shares at avg. $129.59$1.3M - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect1.5K shares at avg. $130.01$195K - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Direct1.2K shares at avg. $129.65$149K - Aug 27, 2025WGS
GeneDx Holdings Corp.
Sale(S)Indirect8.8K shares at avg. $125.07$1.1M - Jun 18, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct12.9K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
3.6K shares- - Feb 21, 2025OMIC
Singular Genomics Systems, Inc.
Disposition(D)DirectStock Option (Right to Buy)
2.5K shares at avg. $8.84- - Feb 21, 2025OMIC
Singular Genomics Systems, Inc.
Disposition(D)DirectStock Option (Right to Buy)
1.3K shares- - Feb 21, 2025OMIC
Singular Genomics Systems, Inc.
Disposition(D)DirectStock Option (Right to Buy)
1.5K shares- - Feb 21, 2025OMIC
Singular Genomics Systems, Inc.
Disposition(D)DirectStock Option (Right to Buy)
2.5K shares- - Nov 20, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect9.4K shares at avg. $68.36$640K - Nov 20, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect4.3K shares at avg. $70.50$301K - Nov 20, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect1.9K shares at avg. $69.84$130K - Nov 19, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect24.8K shares at avg. $71.35$1.8M - Nov 19, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect774 shares at avg. $72.26$56K - Nov 19, 2024WGS
GeneDx Holdings Corp.
Gift(G)Indirect141.4K shares- - Nov 19, 2024WGS
GeneDx Holdings Corp.
Sale(S)Indirect6K shares at avg. $70.86$422K - Oct 15, 2024WGS
GeneDx Holdings Corp.
Exercise(M)Direct130 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  WGS GeneDx Holdings Corp. | Exercise(M) | 3,576 | - | $0 | Direct |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 8,969 | $126.15 | $1,131,472 | Indirect |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 5,443 | $127.44 | $693,641 | Indirect |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 3,452 | $128.04 | $441,997 | Indirect |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 9,890 | $129.59 | $1,281,690 | Indirect |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 1,500 | $130.01 | $195,015 | Indirect |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 1,150 | $129.65 | $149,093 | Direct |
| Aug 27, 2025 | WGS GeneDx Holdings Corp. | Sale(S) | 8,818 | $125.07 | $1,102,893 | Indirect |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 12,924 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 3,576 | - | - | Direct |
| Feb 21, 2025 |  OMIC Singular Genomics Systems, Inc. | Disposition(D) Stock Option (Right to Buy) | 2,466 | $8.84 | - | Direct |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | Disposition(D) Stock Option (Right to Buy) | 1,333 | - | - | Direct |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | Disposition(D) Stock Option (Right to Buy) | 1,541 | - | - | Direct |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | Disposition(D) Stock Option (Right to Buy) | 2,466 | - | - | Direct |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 9,361 | $68.36 | $639,876 | Indirect |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 4,272 | $70.50 | $301,185 | Indirect |
| Nov 20, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 1,857 | $69.84 | $129,689 | Indirect |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 24,784 | $71.35 | $1,768,420 | Indirect |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 774 | $72.26 | $55,927 | Indirect |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | Gift(G) | 141,356 | - | $0 | Indirect |
| Nov 19, 2024 | WGS GeneDx Holdings Corp. | Sale(S) | 5,952 | $70.86 | $421,784 | Indirect |
| Oct 15, 2024 | WGS GeneDx Holdings Corp. | Exercise(M) | 130 | - | $0 | Direct |
1-22 of 22 transactions
About Ryan Jason
Ryan Jason (SEC CIK 0001585017) files insider reports with the SEC as Director of GeneDx Holdings Corp. (WGS) and Director of Singular Genomics Systems, Inc. (OMIC).
Signal8 holds 6 ownership filings by Ryan Jason, all Form 4s, filed between Oct 17, 2024 and Jun 23, 2026. Those filings report 22 transactions, from Oct 15, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ryan Jason's filings is in STAMFORD, CT.
Recent filings by Ryan Jason
- Jun 18, 2026: Option exercise of WGS shares (Form 4, code M).
- Aug 27, 2025: Open-market sales of WGS shares (7 lines, Form 4, code S).
- Jun 18, 2025: Option exercise of WGS shares (Form 4, code M).
- Jun 18, 2025: Grant or award of WGS derivative securities (Form 4, code A).
- Feb 21, 2025: Disposition to issuer transactions of OMIC derivative securities (4 lines, Form 4, code D).
Other insiders filing for GeneDx Holdings Corp. (WGS)
- Stueland Katherine, CHIEF EXECUTIVE OFFICER
- Feeley Kevin, CHIEF FINANCIAL OFFICER
- Fuchs Thomas, Director
- GARDNER MARK A, President
- RUCH JOSHUA, Director
- PFENNIGER RICHARD C JR, Director